BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32613314)

  • 1. Severe immune thrombocytopenic purpura in critical COVID-19.
    Lévesque V; Millaire É; Corsilli D; Rioux-Massé B; Carrier FM
    Int J Hematol; 2020 Nov; 112(5):746-750. PubMed ID: 32613314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe immune thrombocytopenia in a critically ill COVID-19 patient.
    Martincic Z; Skopec B; Rener K; Mavric M; Vovko T; Jereb M; Lukic M
    Int J Infect Dis; 2020 Oct; 99():269-271. PubMed ID: 32771636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 patient with immune thrombocytopenic purpura.
    Kewan T; Almhana F; Schwartzman L; Daw H; Haddad A
    Int J Lab Hematol; 2020 Dec; 42(6):e260-e262. PubMed ID: 32786138
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19-associated immune thrombocytopenia.
    Bomhof G; Mutsaers PGNJ; Leebeek FWG; Te Boekhorst PAW; Hofland J; Croles FN; Jansen AJG
    Br J Haematol; 2020 Jul; 190(2):e61-e64. PubMed ID: 32420612
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 as a cause of immune thrombocytopenia.
    Humbert S; Razanamahery J; Payet-Revest C; Bouiller K; Chirouze C
    Med Mal Infect; 2020 Aug; 50(5):459-460. PubMed ID: 32445664
    [No Abstract]   [Full Text] [Related]  

  • 6. Covid-19 associated autoimmune thrombotic thrombocytopenic purpura: Report of a case.
    Hindilerden F; Yonal-Hindilerden I; Akar E; Kart-Yasar K
    Thromb Res; 2020 Nov; 195():136-138. PubMed ID: 32688098
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection.
    Merli M; Ageno W; Sessa F; Salvini M; Caramazza D; Mora B; Rossi A; Rovelli C; Passamonti F; Grossi P
    Ann Hematol; 2020 Aug; 99(8):1951-1952. PubMed ID: 32529284
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis.
    Artru F; Alberio L; Moradpour D; Stalder G
    BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32641442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial.
    Tomazini BM; Maia IS; Cavalcanti AB; Berwanger O; Rosa RG; Veiga VC; Avezum A; Lopes RD; Bueno FR; Silva MVAO; Baldassare FP; Costa ELV; Moura RAB; Honorato MO; Costa AN; Damiani LP; Lisboa T; Kawano-Dourado L; Zampieri FG; Olivato GB; Righy C; Amendola CP; Roepke RML; Freitas DHM; Forte DN; Freitas FGR; Fernandes CCF; Melro LMG; Junior GFS; Morais DC; Zung S; Machado FR; Azevedo LCP;
    JAMA; 2020 Oct; 324(13):1307-1316. PubMed ID: 32876695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial.
    Maskin LP; Olarte GL; Palizas F; Velo AE; Lurbet MF; Bonelli I; Baredes ND; Rodríguez PO
    Trials; 2020 Aug; 21(1):743. PubMed ID: 32843098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Thrombocytopenic Purpura in a Patient with Covid-19.
    Zulfiqar AA; Lorenzo-Villalba N; Hassler P; Andrès E
    N Engl J Med; 2020 Apr; 382(18):e43. PubMed ID: 32294340
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune thrombocytopenia flare with mild COVID-19 infection in pregnancy: A case report.
    Nesr G; Garnett C; Bailey C; Koshy R; Arami S
    Br J Haematol; 2020 Aug; 190(3):e146-e148. PubMed ID: 32516503
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune thrombocytopenia in a patient with COVID-19.
    Deruelle E; Ben Hadj Salem O; Sep Hieng S; Pichereau C; Outin H; Jamme M
    Int J Hematol; 2020 Dec; 112(6):883-888. PubMed ID: 32677007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Thrombocytopenia (ITP) in a Pediatric Patient Positive for SARS-CoV-2.
    Tsao HS; Chason HM; Fearon DM
    Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32439817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune thrombocytopenia and COVID-19: Case report and review of literature.
    Alonso-Beato R; Morales-Ortega A; Fernández FJH; Morón AIP; Ríos-Fernández R; Rubio JLC; Centeno NO
    Lupus; 2021 Aug; 30(9):1515-1521. PubMed ID: 34053365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Treatment of Immune Thrombocytopenic Purpura with Intracranial Hemorrhaging and Duodenal Bleeding Following SARS-CoV-2 Vaccination.
    Baba Y; Sakai H; Kabasawa N; Harada H
    Intern Med; 2022 Jun; 61(12):1891-1895. PubMed ID: 35400701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prone positioning in awake non-ICU patients with ARDS caused by COVID-19.
    Taboada M; Rodríguez N; Riveiro V; Baluja A; Atanassoff PG
    Anaesth Crit Care Pain Med; 2020 Oct; 39(5):581-583. PubMed ID: 32828956
    [No Abstract]   [Full Text] [Related]  

  • 18. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
    J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subphenotyping Acute Respiratory Distress Syndrome in Patients with COVID-19: Consequences for Ventilator Management.
    Bos LDJ; Paulus F; Vlaar APJ; Beenen LFM; Schultz MJ
    Ann Am Thorac Soc; 2020 Sep; 17(9):1161-1163. PubMed ID: 32396457
    [No Abstract]   [Full Text] [Related]  

  • 20. Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic.
    Pavord S; Thachil J; Hunt BJ; Murphy M; Lowe G; Laffan M; Makris M; Newland AC; Provan D; Grainger JD; Hill QA
    Br J Haematol; 2020 Jun; 189(6):1038-1043. PubMed ID: 32374026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.